|
Exhibit 10.1
UNITED STATES DEPARTMENT OF THE TREASURY
1500 PENNSYLVANIA AVENUE, NW
WASHINGTON, D.C. 20220
Dear Ladies and Gentlemen:
The company set forth on the signature page hereto (the "
Company ") intends to issue in a private placement the
number of shares of a series of its preferred stock set forth on
Schedule A hereto (the " Preferred Shares ") and a warrant
to purchase the number of shares of its common stock set forth on
Schedule A hereto (the " Warrant " and, together with the
Preferred Shares, the " Purchased Securities ") and the
United States Department of the Treasury (the " Investor ")
intends to purchase from the Company the Purchased Securities.
The purpose of this letter agreement is to confirm the terms and
conditions of the purchase by the Investor of the Purchased
Securities. Except to the extent supplemented or superseded by the
terms set forth herein or in the Schedules hereto, the provisions
contained in the Securities Purchase Agreement – Standard
Terms attached hereto as Exhibit A (the " Securities Purchase
Agreement ") are incorporated by reference herein. Terms that
are defined in the Securities Purchase Agreement are used in this
letter agreement as so defined. In the event of any inconsistency
between this letter agreement and the Securities Purchase
Agreement, the terms of this letter agreement shall govern.
Each of the Company and the Investor hereby confirms its
agreement with the other party with respect to the issuance by the
Company of the Purchased Securities and the purchase by the
Investor of the Purchased Securities pursuant to this letter
agreement and the Securities Purchase Agreement on the terms
specified on Schedule A hereto.
This letter agreement (including the Schedules hereto) and the
Securities Purchase Agreement (including the Annexes thereto) and
the Warrant constitute the entire agreement, and supersede all
other prior agreements, understandings, representations and
warranties, both written and oral, between the parties, with
respect to the subject matter hereof. This letter agreement
constitutes the "Letter Agreement" referred to in the Securities
Purchase Agreement.
This letter agreement may be executed in any number of separate
counterparts, each such counterpart being deemed to be an original
instrument, and all such counterparts will together constitute the
same agreement. Executed signature pages to this letter agreement
may be delivered by facsimile and such facsimiles will be deemed as
sufficient as if actual signature pages had been delivered.
* * *
IN WITNESS WHEREOF, this letter agreement has
been duly executed and delivered by the duly authorized
representatives of the parties hereto as of the date written
below.
| |
|
|
|
UNITED STATES DEPARTMENT OF THE
TREASURY
|
|
|
|
By:
|
|
/s/ Neel Kashkari
|
|
Name:
|
|
Neel Kashkari
|
|
Title:
|
|
Interim Assistant Secretary for Financial
Stability
|
|
|
SUSQUEHANNA BANCSHARES, INC.
|
|
|
|
By:
|
|
/s/ William J. Reuter
|
|
Name:
|
|
William J. Reuter
|
|
Title:
|
|
Chairman and Chief Executive Officer
|
|
Date:
|
|
December 12, 2008
|
EXHIBIT A
SECURITIES PURCHASE AGREEMENT
EXHIBIT A
SECURITIES PURCHASE
AGREEMENT
STANDARD TERMS
TABLE OF
CONTENTS
| |
|
|
|
|
|
|
|
|
|
Page
|
| |
|
Article I
|
|
|
|
|
|
| |
|
Purchase; Closing
|
|
|
|
|
|
|
1.1
|
|
Purchase
|
|
1
|
|
1.2
|
|
Closing
|
|
2
|
|
1.3
|
|
Interpretation
|
|
4
|
|
|
|
| |
|
Article II
|
|
|
|
|
|
| |
|
Representations and
Warranties
|
|
|
|
|
|
|
2.1
|
|
Disclosure
|
|
4
|
|
2.2
|
|
Representations and Warranties of the
Company
|
|
5
|
|
|
|
| |
|
Article III
|
|
|
|
|
|
| |
|
Covenants
|
|
|
|
|
|
|
3.1
|
|
Commercially Reasonable Efforts
|
|
13
|
|
3.2
|
|
Expenses
|
|
14
|
|
3.3
|
|
Sufficiency of Authorized Common Stock; Exchange
Listing
|
|
14
|
|
3.4
|
|
Certain Notifications Until Closing
|
|
15
|
|
3.5
|
|
Access, Information and
Confidentiality
|
|
15
|
|
|
|
| |
|
Article IV
|
|
|
|
|
|
| |
|
Additional Agreements
|
|
|
|
|
|
|
4.1
|
|
Purchase for Investment
|
|
16
|
|
4.2
|
|
Legends
|
|
16
|
|
4.3
|
|
Certain Transactions
|
|
18
|
|
4.4
|
|
Transfer of Purchased Securities and Warrant
Shares; Restrictions on Exercise of the Warrant
|
|
18
|
|
4.5
|
|
Registration Rights.
|
|
18
|
|
4.6
|
|
Voting of Warrant Shares
|
|
30
|
|
4.7
|
|
Depositary Shares
|
|
30
|
|
4.8
|
|
Restriction on Dividends and
Repurchases
|
|
30
|
|
4.9
|
|
Repurchase of Investor Securities
|
|
32
|
|
4.10
|
|
Executive Compensation
|
|
33
|
-i-
| |
|
|
|
|
|
|
|
Article V
|
|
|
|
|
|
| |
|
Miscellaneous
|
|
|
|
|
|
|
5.1
|
|
Termination
|
|
33
|
|
5.2
|
|
Survival of Representations and
Warranties
|
|
33
|
|
5.3
|
|
Amendment
|
|
34
|
|
5.4
|
|
Waiver of Conditions
|
|
34
|
|
5.5
|
|
Governing Law: Submission to Jurisdiction,
Etc.
|
|
34
|
|
5.6
|
|
Notices
|
|
34
|
|
5.7
|
|
Definitions
|
|
35
|
|
5.8
|
|
Assignment
|
|
35
|
|
5.9
|
|
Severability
|
|
35
|
|
5.10
|
|
No Third Party Beneficiaries
|
|
36
|
-ii-
LIST OF ANNEXES
ANNEX A: FORM OF CERTIFICATE OF DESIGNATIONS FOR PREFERRED
STOCK
ANNEX B: FORM OF WAIVER
ANNEX C: FORM OF OPINION
ANNEX D: FORM OF WARRANT
-iii-
INDEX OF DEFINED TERMS
| |
|
|
|
Term
|
|
Location of Definition
|
|
Affiliate
|
|
5.7(b)
|
|
Agreement
|
|
Recitals
|
|
Appraisal Procedure
|
|
4.9(c)(i)
|
|
Appropriate Federal Banking Agency
|
|
2.2(s)
|
|
Bankruptcy Exceptions
|
|
2.2(d)
|
|
Benefit Plans
|
|
1.2(d)(iv)
|
|
Board of Directors
|
|
2.2(f)
|
|
Business Combination
|
|
4.4
|
|
business day
|
|
1.3
|
|
Capitalization Date
|
|
2.2(b)
|
|
Certificate of Designations
|
|
1.2(d)(iii)
|
|
Charter
|
|
1.2(d)(iii)
|
|
Closing
|
|
1.2(a)
|
|
Closing Date
|
|
1.2(a)
|
|
Code
|
|
2.2(n)
|
|
Common Stock
|
|
Recitals
|
|
Company
|
|
Recitals
|
|
Company Financial Statements
|
|
2.2(h)
|
|
Company Material Adverse Effect
|
|
2.1(a)
|
|
Company Reports
|
|
2.2(i)(i)
|
|
Company Subsidiary; Company
Subsidiaries
|
|
2.2(i)(i)
|
|
control; controlled by; under common control
with
|
|
5.7(b)
|
|
Controlled Group
|
|
2.2(n)
|
|
CPP
|
|
Recitals
|
|
EESA
|
|
1.2(d)(iv)
|
|
ERISA
|
|
2.2(n)
|
|
Exchange Act
|
|
2.1(b)
|
|
Fair Market Value
|
|
4.9(c)(ii)
|
|
GAAP
|
|
2.1(a)
|
|
Governmental Entities
|
|
1.2(c)
|
|
Holder
|
|
4.5(k)(i)
|
|
Holders’ Counsel
|
|
4.5(k)(ii)
|
|
Indemnitee
|
|
4.5(g)(i)
|
|
Information
|
|
3.5(b)
|
|
Initial Warrant Shares
|
|
Recitals
|
|
Investor
|
|
Recitals
|
|
Junior Stock
|
|
4.8(c)
|
|
knowledge of the Company; Company’s
knowledge
|
|
5.7(c)
|
|
Last Fiscal Year
|
|
2.1(b)
|
|
Letter Agreement
|
|
Recitals
|
|
officers
|
|
5.7(c)
|
|
Parity Stock
|
|
4.8(c)
|
|
Pending Underwritten Offering
|
|
4.5(l)
|
|
Permitted Repurchases
|
|
4.8(a)(ii)
|
|
Piggyback Registration
|
|
4.5(a)(iv)
|
|
Plan
|
|
2.2(n)
|
|
Preferred Shares
|
|
Recitals
|
|
Preferred Stock
|
|
Recitals
|
|
Previously Disclosed
|
|
2.1(b)
|
|
Proprietary Rights
|
|
2.2(u)
|
|
Purchase
|
|
Recitals
|
-iv-
| |
|
|
|
Term
|
|
Location of Definition
|
|
Purchase Price
|
|
1.1
|
|
Purchased Securities
|
|
Recitals
|
|
Qualified Equity Offering
|
|
4.4
|
|
register; registered; registration
|
|
4.5(k)(iii)
|
|
Registrable Securities
|
|
4.5(k)(iv)
|
|
Registration Expenses
|
|
4.5(k)(v)
|
|
Regulatory Agreement
|
|
2.2(s)
|
|
Rule 144; Rule 144A; Rule 159A; Rule 405; Rule
415
|
|
4.5(k)(vi)
|
|
Schedules
|
|
Recitals
|
|
SEC
|
|
2.1(b)
|
|
Securities Act
|
|
2.2(a)
|
|
Selling Expenses
|
|
4.5(k)(vii)
|
|
Senior Executive Officers
|
|
4.10
|
|
Share Dilution Amount
|
|
4.8(a)(ii)
|
|
Shelf Registration Statement
|
|
4.5(a)(ii)
|
|
Signing Date
|
|
2.1(a)
|
|
Special Registration
|
|
4.5(i)
|
|
Stockholder Proposals
|
|
3.1(b)
|
|
subsidiary
|
|
5.8(a)
|
|
Tax; Taxes
|
|
2.2(o)
|
|
Transfer
|
|
4.4
|
|
Warrant
|
|
Recitals
|
|
Warrant Shares
|
|
2.2(d)
|
-v-
SECURITIES PURCHASE AGREEMENT
– STANDARD TERMS
Recitals:
WHEREAS, the United States Department of the Treasury (the "
Investor ") may from time to time agree to purchase shares
of preferred stock and warrants from eligible financial
institutions which elect to participate in the Troubled Asset
Relief Program Capital Purchase Program (" CPP ");
WHEREAS, an eligible financial institution electing to
participate in the CPP and issue securities to the Investor
(referred to herein as the " Company ") shall enter into a
letter agreement (the " Letter Agreement ") with the
Investor which incorporates this Securities Purchase Agreement
– Standard Terms;
WHEREAS, the Company agrees to expand the flow of credit to U.S.
consumers and businesses on competitive terms to promote the
sustained growth and vitality of the U.S. economy;
WHEREAS, the Company agrees to work diligently, under existing
programs, to modify the terms of residential mortgages as
appropriate to strengthen the health of the U.S. housing
market;
WHEREAS, the Company intends to issue in a private placement the
number of shares of the series of its Preferred Stock ("
Preferred Stock ") set forth on Schedule A to the
Letter Agreement (the " Preferred Shares ") and a warrant to
purchase the number of shares of its Common Stock (" Common
Stock ") set forth on Schedule A to the Letter Agreement
(the " Initial Warrant Shares ") (the " Warrant "
and, together with the Preferred Shares, the " Purchased
Securities ") and the Investor intends to purchase (the "
Purchase ") from the Company the Purchased Securities;
and
WHEREAS, the Purchase will be governed by this Securities
Purchase Agreement – Standard Terms and the Letter Agreement,
including the schedules thereto (the " Schedules "),
specifying additional terms of the Purchase. This Securities
Purchase Agreement – Standard Terms (including the Annexes
hereto) and the Letter Agreement (including the Schedules thereto)
are together referred to as this "Agreement". All references in
this Securities Purchase Agreement – Standard Terms to
"Schedules" are to the Schedules attached to the Letter
Agreement.
NOW, THEREFORE , in consideration of the premises, and of
the representations, warranties, covenants and agreements set forth
herein, the parties agree as follows:
Article I
Purchase; Closing
1.1 Purchase . On the terms and subject to the conditions
set forth in this Agreement, the Company agrees to sell to the
Investor, and the Investor agrees to purchase from the Company, at
the Closing (as hereinafter defined), the Purchased Securities for
the price set forth on Schedule A (the " Purchase Price
").
1.2 Closing .
(a) On the terms and subject to the conditions set forth in this
Agreement, the closing of the Purchase (the " Closing ")
will take place at the location specified in Schedule A , at
the time and on the date set forth in Schedule A or as soon
as practicable thereafter, or at such other place, time and date as
shall be agreed between the Company and the Investor. The time and
date on which the Closing occurs is referred to in this Agreement
as the " Closing Date ".
(b) Subject to the fulfillment or waiver of the conditions to
the Closing in this Section 1.2, at the Closing the Company
will deliver the Preferred Shares and the Warrant, in each case as
evidenced by one or more certificates dated the Closing Date and
bearing appropriate legends as hereinafter provided for, in
exchange for payment in full of the Purchase Price by wire transfer
of immediately available United States funds to a bank account
designated by the Company on Schedule A .
(c) The respective obligations of each of the Investor and the
Company to consummate the Purchase are subject to the fulfillment
(or waiver by the Investor and the Company, as applicable) prior to
the Closing of the conditions that (i) any approvals or
authorizations of all United States and other governmental,
regulatory or judicial authorities (collectively, " Governmental
Entities ") required for the consummation of the Purchase shall
have been obtained or made in form and substance reasonably
satisfactory to each party and shall be in full force and effect
and all waiting periods required by United States and other
applicable law, if any, shall have expired and (ii) no
provision of any applicable United States or other law and no
judgment, injunction, order or decree of any Governmental Entity
shall prohibit the purchase and sale of the Purchased Securities as
contemplated by this Agreement.
(d) The obligation of the Investor to consummate the Purchase is
also subject to the fulfillment (or waiver by the Investor) at or
prior to the Closing of each of the following conditions:
(i) (A) the representations and warranties of the Company set
forth in (x) Section 2.2(g) of this Agreement shall be
true and correct in all respects as though made on and as of the
Closing Date, (y) Sections 2.2(a) through (f) shall be
true and correct in all material respects as though made on and as
of the Closing Date (other than representations and warranties that
by their terms speak as of another date, which representations and
warranties shall be true and correct in all material respects as of
such other date) and (z) Sections 2.2(h) through
(v) (disregarding all qualifications or limitations set forth
in such representations and warranties as to "materiality",
"Company Material Adverse Effect" and words of similar import)
shall be true and correct as though made on and as of the Closing
Date (other than representations and warranties that by their terms
speak as of another date, which representations and warranties
shall be true and correct as of such other date), except to the
extent that the failure of such representations and warranties
referred to in this Section 1.2(d)(i)(A)(z) to be so true and
correct, individually or in the aggregate, does not have and would
not reasonably be expected to have a Company Material Adverse
Effect and (B) the Company shall have performed in all
material respects all obligations required to be performed by it
under this Agreement at or prior to the Closing;
-2-
(ii) the Investor shall have received a
certificate signed on behalf of the Company by a senior executive
officer certifying to the effect that the conditions set forth in
Section 1.2(d)(i) have been satisfied;
(iii) the Company shall have duly adopted and filed with the
Secretary of State of its jurisdiction of organization or other
applicable Governmental Entity the amendment to its certificate or
articles of incorporation, articles of association, or similar
organizational document (" Charter ") in substantially the
form attached hereto as Annex A (the " Certificate of
Designations ") and such filing shall have been accepted;
(iv) (A) the Company shall have effected such changes to its
compensation, bonus, incentive and other benefit plans,
arrangements and agreements (including golden parachute, severance
and employment agreements) (collectively, " Benefit Plans ")
with respect to its Senior Executive Officers (and to the extent
necessary for such changes to be legally enforceable, each of its
Senior Executive Officers shall have duly consented in writing to
such changes), as may be necessary, during the period that the
Investor owns any debt or equity securities of the Company acquired
pursuant to this Agreement or the Warrant, in order to comply with
Section 111(b) of the Emergency Economic Stabilization Act of
2008 (" EESA ") as implemented by guidance or regulation
thereunder that has been issued and is in effect as of the Closing
Date, and (B) the Investor shall have received a certificate
signed on behalf of the Company by a senior executive officer
certifying to the effect that the condition set forth in
Section 1.2(d)(iv)(A) has been satisfied;
(v) each of the Company’s Senior Executive Officers shall
have delivered to the Investor a written waiver in the form
attached hereto as Annex B releasing the Investor from any
claims that such Senior Executive Officers may otherwise have as a
result of the issuance, on or prior to the Closing Date, of any
regulations which require the modification of, and the agreement of
the Company hereunder to modify, the terms of any Benefit Plans
with respect to its Senior Executive Officers to eliminate any
provisions of such Benefit Plans that would not be in compliance
with the requirements of Section 111(b) of the EESA as
implemented by guidance or regulation thereunder that has been
issued and is in effect as of the Closing Date;
(vi) the Company shall have delivered to the Investor a written
opinion from counsel to the Company (which may be internal
counsel), addressed to the Investor and dated as of the Closing
Date, in substantially the form attached hereto as Annex C
;
(vii) the Company shall have delivered certificates in proper
form or, with the prior consent of the Investor, evidence of shares
in book-entry form, evidencing the Preferred Shares to Investor or
its designee(s); and
-3-
(viii) the Company shall have duly executed the
Warrant in substantially the form attached hereto as Annex D
and delivered such executed Warrant to the Investor or its
designee(s).
1.3 Interpretation . When a reference is made in this
Agreement to "Recitals," "Articles," "Sections," or "Annexes" such
reference shall be to a Recital, Article or Section of, or Annex
to, this Securities Purchase Agreement – Standard Terms, and
a reference to "Schedules" shall be to a Schedule to the Letter
Agreement, in each case, unless otherwise indicated. The terms
defined in the singular have a comparable meaning when used in the
plural, and vice versa. References to "herein", "hereof",
"hereunder" and the like refer to this Agreement as a whole and not
to any particular section or provision, unless the context requires
otherwise. The table of contents and headings contained in this
Agreement are for reference purposes only and are not part of this
Agreement. Whenever the words "include," "includes" or "including"
are used in this Agreement, they shall be deemed followed by the
words "without limitation." No rule of construction against the
draftsperson shall be applied in connection with the interpretation
or enforcement of this Agreement, as this Agreement is the product
of negotiation between sophisticated parties advised by counsel.
All references to "$" or "dollars" mean the lawful currency of the
United States of America. Except as expressly stated in this
Agreement, all references to any statute, rule or regulation are to
the statute, rule or regulation as amended, modified, supplemented
or replaced from time to time (and, in the case of statutes,
include any rules and regulations promulgated under the statute)
and to any section of any statute, rule or regulation include any
successor to the section. References to a " business day "
shall mean any day except Saturday, Sunday and any day on which
banking institutions in the State of New York generally are
authorized or required by law or other governmental actions to
close.
Article II
Representations and Warranties
2.1 Disclosure .
(a) " Company Material Adverse Effect " means a material
adverse effect on (i) the business, results of operation or
financial condition of the Company and its consolidated
subsidiaries taken as a whole; provided , however ,
that Company Material Adverse Effect shall not be deemed to include
the effects of (A) changes after the date of the Letter
Agreement (the " Signing Date ") in general business,
economic or market conditions (including changes generally in
prevailing interest rates, credit availability and liquidity,
currency exchange rates and price levels or trading volumes in the
United States or foreign securities or credit markets), or any
outbreak or escalation of hostilities, declared or undeclared acts
of war or terrorism, in each case generally affecting the
industries in which the Company and its subsidiaries operate,
(B) changes or proposed changes after the Signing Date in
generally accepted accounting principles in the United States ("
GAAP ") or regulatory accounting requirements, or
authoritative interpretations thereof, (C) changes or proposed
changes after the Signing Date in securities, banking and other
laws of general applicability or related policies or
interpretations of Governmental Entities (in the case of each of
these clauses (A), (B) and (C), other than changes or
occurrences to the extent that such changes or occurrences have or
would reasonably be expected to have a materially
-4-
disproportionate adverse effect on the Company
and its consolidated subsidiaries taken as a whole relative to
comparable U.S. banking or financial services organizations), or
(D) changes in the market price or trading volume of the
Common Stock or any other equity, equity-related or debt securities
of the Company or its consolidated subsidiaries (it being
understood and agreed that the exception set forth in this clause
(D) does not apply to the underlying reason giving rise to or
contributing to any such change); or (ii) the ability of the
Company to consummate the Purchase and the other transactions
contemplated by this Agreement and the Warrant and perform its
obligations hereunder or thereunder on a timely basis.
(b) " Previously Disclosed " means information set forth
or incorporated in the Company’s Annual Report on Form 10-K
for the most recently completed fiscal year of the Company filed
with the Securities and Exchange Commission (the " SEC ")
prior to the Signing Date (the " Last Fiscal Year ") or in
its other reports and forms filed with or furnished to the SEC
under Sections 13(a), 14(a) or 15(d) of the Securities Exchange Act
of 1934 (the " Exchange Act ") on or after the last day of
the Last Fiscal Year and prior to the Signing Date.
2.2 Representations and Warranties of the Company .
Except as Previously Disclosed, the Company represents and warrants
to the Investor that as of the Signing Date and as of the Closing
Date (or such other date specified herein):
(a) Organization, Authority and Significant Subsidiaries
. The Company has been duly incorporated and is validly existing
and in good standing under the laws of its jurisdiction of
organization, with the necessary power and authority to own its
properties and conduct its business in all material respects as
currently conducted, and except as has not, individually or in the
aggregate, had and would not reasonably be expected to have a
Company Material Adverse Effect, has been duly qualified as a
foreign corporation for the transaction of business and is in good
standing under the laws of each other jurisdiction in which it owns
or leases properties or conducts any business so as to require such
qualification; each subsidiary of the Company that is a
"significant subsidiary" within the meaning of Rule 1-02(w) of
Regulation S-X under the Securities Act of 1933 (the "
Securities Act ") has been duly organized and is validly
existing in good standing under the laws of its jurisdiction of
organization. The Charter and bylaws of the Company, copies of
which have been provided to the Investor prior to the Signing Date,
are true, complete and correct copies of such documents as in full
force and effect as of the Signing Date.
(b) Capitalization . The authorized capital stock of the
Company, and the outstanding capital stock of the Company
(including securities convertible into, or exercisable or
exchangeable for, capital stock of the Company) as of the most
recent fiscal month-end preceding the Signing Date (the "
Capitalization Date ") is set forth on Schedule B .
The outstanding shares of capital stock of the Company have been
duly authorized and are validly issued and outstanding, fully paid
and nonassessable, and subject to no preemptive rights (and were
not issued in violation of any preemptive rights). Except as
provided in the Warrant, as of the Signing Date, the Company does
not have outstanding any securities or other obligations providing
the holder the right to acquire Common Stock that is not reserved
for issuance as specified on Schedule B , and the Company
has not made any other commitment to authorize, issue or sell any
Common Stock. Since the Capitalization Date, the Company has not
issued any shares of Common Stock,
-5-
other than (i) shares issued upon the
exercise of stock options or delivered under other equity-based
awards or other convertible securities or warrants which were
issued and outstanding on the Capitalization Date and disclosed on
Schedule B and (ii) shares disclosed on Schedule
B .
(c) Preferred Shares . The Preferred Shares have been
duly and validly authorized, and, when issued and delivered
pursuant to this Agreement, such Preferred Shares will be duly and
validly issued and fully paid and non-assessable, will not be
issued in violation of any preemptive rights, and will rank pari
passu with or senior to all other series or classes of
Preferred Stock, whether or not issued or outstanding, with respect
to the payment of dividends and the distribution of assets in the
event of any dissolution, liquidation or winding up of the
Company.
(d) The Warrant and Warrant Shares . The Warrant has been
duly authorized and, when executed and delivered as contemplated
hereby, will constitute a valid and legally binding obligation of
the Company enforceable against the Company in accordance with its
terms, except as the same may be limited by applicable bankruptcy,
insolvency, reorganization, moratorium or similar laws affecting
the enforcement of creditors’ rights generally and general
equitable principles, regardless of whether such enforceability is
considered in a proceeding at law or in equity (" Bankruptcy
Exceptions "). The shares of Common Stock issuable upon
exercise of the Warrant (the " Warrant Shares ") have been
duly authorized and reserved for issuance upon exercise of the
Warrant and when so issued in accordance with the terms of the
Warrant will be validly issued, fully paid and non-assessable,
subject, if applicable, to the approvals of its stockholders set
forth on Schedule C .
(e) Authorization, Enforceability .
(i) The Company has the corporate power and authority to execute
and deliver this Agreement and the Warrant and, subject, if
applicable, to the approvals of its stockholders set forth on
Schedule C , to carry out its obligations hereunder and
thereunder (which includes the issuance of the Preferred Shares,
Warrant and Warrant Shares). The execution, delivery and
performance by the Company of this Agreement and the Warrant and
the consummation of the transactions contemplated hereby and
thereby have been duly authorized by all necessary corporate action
on the part of the Company and its stockholders, and no further
approval or authorization is required on the part of the Company,
subject, in each case, if applicable, to the approvals of its
stockholders set forth on Schedule C . This Agreement is a
valid and binding obligation of the Company enforceable against the
Company in accordance with its terms, subject to the Bankruptcy
Exceptions.
(ii) The execution, delivery and performance by the Company of
this Agreement and the Warrant and the consummation of the
transactions contemplated hereby and thereby and compliance by the
Company with the provisions hereof and thereof, will not
(A) violate, conflict with, or result in a breach of any
provision of, or constitute a default (or an event which, with
notice or lapse of time or both, would constitute a default) under,
or result in the termination of, or accelerate the performance
required
-6-
by, or result in a right of termination or
acceleration of, or result in the creation of, any lien, security
interest, charge or encumbrance upon any of the properties or
assets of the Company or any Company Subsidiary under any of the
terms, conditions or provisions of (i) subject, if applicable,
to the approvals of the Company’s stockholders set forth on
Schedule C , its organizational documents or (ii) any
note, bond, mortgage, indenture, deed of trust, license, lease,
agreement or other instrument or obligation to which the Company or
any Company Subsidiary is a party or by which it or any Company
Subsidiary may be bound, or to which the Company or any Company
Subsidiary or any of the properties or assets of the Company or any
Company Subsidiary may be subject, or (B) subject to
compliance with the statutes and regulations referred to in the
next paragraph, violate any statute, rule or regulation or any
judgment, ruling, order, writ, injunction or decree applicable to
the Company or any Company Subsidiary or any of their respective
properties or assets except, in the case of clauses (A)(ii) and
(B), for those occurrences that, individually or in the aggregate,
have not had and would not reasonably be expected to have a Company
Material Adverse Effect.
(iii) Other than the filing of the Certificate of Designations
with the Secretary of State of its jurisdiction of organization or
other applicable Governmental Entity, any current report on Form
8-K required to be filed with the SEC, such filings and approvals
as are required to be made or obtained under any state "blue sky"
laws, the filing of any proxy statement contemplated by
Section 3.1 and such as have been made or obtained, no notice
to, filing with, exemption or review by, or authorization, consent
or approval of, any Governmental Entity is required to be made or
obtained by the Company in connection with the consummation by the
Company of the Purchase except for any such notices, filings,
exemptions, reviews, authorizations, consents and approvals the
failure of which to make or obtain would not, individually or in
the aggregate, reasonably be expected to have a Company Material
Adverse Effect.
(f) Anti-takeover Provisions and Rights Plan . The Board
of Directors of the Company (the " Board of Directors ") has
taken all necessary action to ensure that the transactions
contemplated by this Agreement and the Warrant and the consummation
of the transactions contemplated hereby and thereby, including the
exercise of the Warrant in accordance with its terms, will be
exempt from any anti-takeover or similar provisions of the
Company’s Charter and bylaws, and any other provisions of any
applicable "moratorium", "control share", "fair price", "interested
stockholder" or other anti-takeover laws and regulations of any
jurisdiction. The Company has taken all actions necessary to render
any stockholders’ rights plan of the Company inapplicable to
this Agreement and the Warrant and the consummation of the
transactions contemplated hereby and thereby, including the
exercise of the Warrant by the Investor in accordance with its
terms.
(g) No Company Material Adverse Effect . Since the last
day of the last completed fiscal period for which the Company has
filed a Quarterly Report on Form 10-Q or an Annual Report on Form
10-K with the SEC prior to the Signing Date, no fact, circumstance,
event, change, occurrence, condition or development has occurred
that, individually or in the aggregate, has had or would reasonably
be expected to have a Company Material Adverse Effect.
-7-
(h) Company Financial Statements . Each of
the consolidated financial statements of the Company and its
consolidated subsidiaries (collectively the " Company Financial
Statements ") included or incorporated by reference in the
Company Reports filed with the SEC since December 31, 2006,
present fairly in all material respects the consolidated financial
position of the Company and its consolidated subsidiaries as of the
dates indicated therein (or if amended prior to the Signing Date,
as of the date of such amendment) and the consolidated results of
their operations for the periods specified therein; and except as
stated therein, such financial statements (A) were prepared in
conformity with GAAP applied on a consistent basis (except as may
be noted therein), (B) have been prepared from, and are in
accordance with, the books and records of the Company and the
Company Subsidiaries and (C) complied as to form, as of their
respective dates of filing with the SEC, in all material respects
with the applicable accounting requirements and with the published
rules and regulations of the SEC with respect thereto.
(i) Reports .
(i) Since December 31, 2006, the Company and each
subsidiary of the Company (each a " Company Subsidiary "
and, collectively, the " Company Subsidiaries ") has timely
filed all reports, registrations, documents, filings, statements
and submissions, together with any amendments thereto, that it was
required to file with any Governmental Entity (the foregoing,
collectively, the " Company Reports ") and has paid all fees
and assessments due and payable in connection therewith, except, in
each case, as would not, individually or in the aggregate,
reasonably be expected to have a Company Material Adverse Effect.
As of their respective dates of filing, the Company Reports
complied in all material respects with all statutes and applicable
rules and regulations of the applicable Governmental Entities. In
the case of each such Company Report filed with or furnished to the
SEC, such Company Report (A) did not, as of its date or if
amended prior to the Signing Date, as of the date of such
amendment, contain an untrue statement of a material fact or omit
to state a material fact necessary in order to make the statements
made therein, in light of the circumstances under which they were
made, not misleading, and (B) complied as to form in all
material respects with the applicable requirements of the
Securities Act and the Exchange Act. With respect to all other
Company Reports, the Company Reports were complete and accurate in
all material respects as of their respective dates. No executive
officer of the Company or any Company Subsidiary has failed in any
respect to make the certifications required of him or her under
Section 302 or 906 of the Sarbanes-Oxley Act of 2002.
(ii) The records, systems, controls, data and information of the
Company and the Company Subsidiaries are recorded, stored,
maintained and operated under means (including any electronic,
mechanical or photographic process, whether computerized or not)
that are under the exclusive ownership and direct control of the
Company or the Company Subsidiaries or their accountants (including
all means of access thereto and therefrom), except for any
non-exclusive ownership and non-direct control that would not
reasonably be expected to have a material adverse effect on the
system of internal accounting controls described below in this
Section 2.2(i)(ii). The Company (A) has implemented and
maintains disclosure controls and procedures (as defined in
Rule 13a-15(e) of the Exchange Act) to ensure that material
information relating to the Company, including the
-8-
consolidated Company Subsidiaries, is made known
to the chief executive officer and the chief financial officer of
the Company by others within those entities, and (B) has
disclosed, based on its most recent evaluation prior to the Signing
Date, to the Company’s outside auditors and the audit
committee of the Board of Directors (x) any significant
deficiencies and material weaknesses in the design or operation of
internal controls over financial reporting (as defined in
Rule 13a-15(f) of the Exchange Act) that are reasonably likely
to adversely affect the Company’s ability to record, process,
summarize and report financial information and (y) any fraud,
whether or not material, that involves management or other
employees who have a significant role in the Company’s
internal controls over financial reporting.
(j) No Undisclosed Liabilities . Neither the Company nor
any of the Company Subsidiaries has any liabilities or obligations
of any nature (absolute, accrued, contingent or otherwise) which
are not properly reflected or reserved against in the Company
Financial Statements to the extent required to be so reflected or
reserved against in accordance with GAAP, except for
(A) liabilities that have arisen since the last fiscal year
end in the ordinary and usual course of business and consistent
with past practice and (B) liabilities that, individually or
in the aggregate, have not had and would not reasonably be expected
to have a Company Material Adverse Effect.
(k) Offering of Securities . Neither the Company nor any
person acting on its behalf has taken any action (including any
offering of any securities of the Company under circumstances which
would require the integration of such offering with the offering of
any of the Purchased Securities under the Securities Act, and the
rules and regulations of the SEC promulgated thereunder), which
might subject the offering, issuance or sale of any of the
Purchased Securities to Investor pursuant to this Agreement to the
registration requirements of the Securities Act.
(l) Litigation and Other Proceedings . Except (i) as
set forth on Schedule D or (ii) as would not,
individually or in the aggregate, reasonably be expected to have a
Company Material Adverse Effect, there is no (A) pending or,
to the knowledge of the Company, threatened, claim, action, suit,
investigation or proceeding, against the Company or any Company
Subsidiary or to which any of their assets are subject nor is the
Company or any Company Subsidiary subject to any order, judgment or
decree or (B) unresolved violation, criticism or exception by
any Governmental Entity with respect to any report or relating to
any examinations or inspections of the Company or any Company
Subsidiaries.
(m) Compliance with Laws. Except as would not,
individually or in the aggregate, reasonably be expected to have a
Company Material Adverse Effect, the Company and the Company
Subsidiaries have all permits, licenses, franchises,
authorizations, orders and approvals of, and have made all filings,
applications and registrations with, Governmental Entities that are
required in order to permit them to own or lease their properties
and assets and to carry on their business as presently conducted
and that are material to the business of the Company or such
Company Subsidiary. Except as set forth on Schedule E , the
Company and the Company Subsidiaries have complied in all respects
and are not in default or violation of, and none of them is, to the
knowledge of the
-9-
Company, under investigation with respect to or,
to the knowledge of the Company, have been threatened to be charged
with or given notice of any violation of, any applicable domestic
(federal, state or local) or foreign law, statute, ordinance,
license, rule, regulation, policy or guideline, order, demand,
writ, injunction, decree or judgment of any Governmental Entity,
other than such noncompliance, defaults or violations that would
not, individually or in the aggregate, reasonably be expected to
have a Company Material Adverse Effect. Except for statutory or
regulatory restrictions of general application or as set forth on
Schedule E , no Governmental Entity has placed any
restriction on the business or properties of the Company or any
Company Subsidiary that would, individually or in the aggregate,
reasonably be expected to have a Company Material Adverse
Effect.
(n) Employee Benefit Matters . Except as would not
reasonably be expected to have, either individually or in the
aggregate, a Company Material Adverse Effect: (A) each
"employee benefit plan" (within the meaning of Section 3(3) of
the Employee Retirement Income Security Act of 1974, as amended ("
ERISA ")) providing benefits to any current or former
employee, officer or director of the Company or any member of its "
Controlled Group " (defined as any organization which is a
member of a controlled group of corporations within the meaning of
Section 414 of the Internal Revenue Code of 1986, as amended
(the " Code ")) that is sponsored, maintained or contributed
to by the Company or any member of its Controlled Group and for
which the Company or any member of its Controlled Group would have
any liability, whether actual or contingent (each, a " Plan
") has been maintained in compliance with its terms and with the
requirements of all applicable statutes, rules and regulations,
including ERISA and the Code; (B) with respect to each Plan
subject to Title IV of ERISA (including, for purposes of this
clause (B), any plan subject to Title IV of ERISA that the Company
or any member of its Controlled Group previously maintained or
contributed to in the six years prior to the Signing Date),
(1) no "reportable event" (within the meaning of
Section 4043(c) of ERISA), other than a reportable event for
which the notice period referred to in Section 4043(c) of
ERISA has been waived, has occurred in the three years prior to the
Signing Date or is reasonably expected to occur, (2) no
"accumulated funding deficiency" (within the meaning of
Section 302 of ERISA or Section 412 of the Code), whether
or not waived, has occurred in the three years prior to the Signing
Date or is reasonably expected to occur, (3) the fair market
value of the assets under each Plan exceeds the present value of
all benefits accrued under such Plan (determined based on the
assumptions used to fund such Plan) and (4) neither the
Company nor any member of its Controlled Group has incurred in the
six years prior to the Signing Date, or reasonably expects to
incur, any liability under Title IV of ERISA (other than
contributions to the Plan or premiums to the PBGC in the ordinary
course and without default) in respect of a Plan (including any
Plan that is a "multiemployer plan", within the meaning of
Section 4001(c)(3) of ERISA); and (C) each Plan that is
intended to be qualified under Section 401(a) of the Code has
received a favorable determination letter from the Internal Revenue
Service with respect to its qualified status that has not been
revoked, or such a determination letter has been timely applied for
but not received by the Signing Date, and nothing has occurred,
whether by action or by failure to act, which could reasonably be
expected to cause the loss, revocation or denial of such qualified
status or favorable determination letter.
(o) Taxes . Except as would not, individually or in the
aggregate, reasonably be expected to have a Company Material
Adverse Effect, (i) the Company and the Company Subsidiaries
have filed all federal, state, local and foreign income and
franchise Tax returns
-10-
required to be filed through the Signing Date,
subject to permitted extensions, and have paid all Taxes due
thereon, and (ii) no Tax deficiency has been determined
adversely to the Company or any of the Company Subsidiaries, nor
does the Company have any knowledge of any Tax deficiencies. "
Tax " or " Taxes " means any federal, state, local or
foreign income, gross receipts, property, sales, use, license,
excise, franchise, employment, payroll, withholding, alternative or
add on minimum, ad valorem, transfer or excise tax, or any other
tax, custom, duty, governmental fee or other like assessment or
charge of any kind whatsoever, together with any interest or
penalty, imposed by any Governmental Entity.
(p) Properties and Leases . Except as would not,
individually or in the aggregate, reasonably be expected to have a
Company Material Adverse Effect, the Company and the Company
Subsidiaries have good and marketable title to all real properties
and all other properties and assets owned by them, in each case
free from liens, encumbrances, claims and defects that would affect
the value thereof or interfere with the use made or to be made
thereof by them. Except as would not, individually or in the
aggregate, reasonably be expected to have a Company Material
Adverse Effect, the Company and the Company Subsidiaries hold all
leased real or personal property under valid and enforceable leases
with no exceptions that would interfere with the use made or to be
made thereof by them.
(q) Environmental Liability . Except as would not,
individually or in the aggregate, reasonably be expected to have a
Company Material Adverse Effect:
(i) there is no legal, administrative, or other proceeding,
claim or action of any nature seeking to impose, or that would
reasonably be expected to result in the imposition of, on the
Company or any Company Subsidiary, any liability relating to the
release of hazardous substances as defined under any local, state
or federal environmental statute, regulation or ordinance,
including the Comprehensive Environmental Response, Compensation
and Liability Act of 1980, pending or, to the Company’s
knowledge, threatened against the Company or any Company
Subsidiary;
(ii) to the Company’s knowledge, there is no reasonable
basis for any such proceeding, claim or action; and
(iii) neither the Company nor any Company Subsidiary is subject
to any agreement, order, judgment or decree by or with any court,
Governmental Entity or third party imposing any such environmental
liability.
(r) Risk Management Instruments . Except as would not,
individually or in the aggregate, reasonably be expected to have a
Company Material Adverse Effect, all derivative instruments,
including, swaps, caps, floors and option agreements, whether
entered into for the Company’s own account, or for the
account of one or more of the Company Subsidiaries or its or their
customers, were entered into (i) only in the ordinary course
of business, (ii) in accordance with prudent practices and in
all material respects with all applicable laws, rules, regulations
and regulatory policies and (iii) with counterparties believed
to be financially responsible at the time; and each of such
instruments constitutes the valid and legally binding obligation of
the Company or one of the Company
-11-
Subsidiaries, enforceable in accordance with its
terms, except as may be limited by the Bankruptcy Exceptions.
Neither the Company or the Company Subsidiaries, nor, to the
knowledge of the Company, any other party thereto, is in breach of
any of its obligations under any such agreement or arrangement
other than such breaches that would not, individually or in the
aggregate, reasonably be expected to have a Company Material
Adverse Effect.
(s) Agreements with Regulatory Agencies . Except as set
forth on Schedule F , neither the Company nor any Company
Subsidiary is subject to any material cease-and-desist or other
similar order or enforcement action issued by, or is a party to any
material written agreement, consent agreement or memorandum of
understanding with, or is a party to any commitment letter or
similar undertaking to, or is subject to any capital directive by,
or since December 31, 2006, has adopted any board resolutions
at the request of, any Governmental Entity (other than the
Appropriate Federal Banking Agencies with jurisdiction over the
Company and the Company Subsidiaries) that currently restricts in
any material respect the conduct of its business or that in any
material manner relates to its capital adequacy, its liquidity and
funding policies and practices, its ability to pay dividends, its
credit, risk management or compliance policies or procedures, its
internal controls, its management or its operations or business
(each item in this sentence, a " Regulatory Agreement "),
nor has the Company or any Company Subsidiary been advised since
December 31, 2006 by any such Governmental Entity that it is
considering issuing, initiating, ordering, or requesting any such
Regulatory Agreement. The Company and each Company Subsidiary are
in compliance in all material respects with each Regulatory
Agreement to which it is party or subject, and neither the Company
nor any Company Subsidiary has received any notice from any
Governmental Entity indicating that either the Company or any
Company Subsidiary is not in compliance in all material respects
with any such Regulatory Agreement. " Appropriate Federal
Banking Agency " means the "appropriate Federal banking agency"
with respect to the Company or such Company Subsidiaries, as
applicable, as defined in Section 3(q) of the Federal Deposit
Insurance Act (12 U.S.C. Section 1813(q)).
(t) Insurance . The Company and the Company Subsidiaries
are insured with reputable insurers against such risks and in such
amounts as the management of the Company reasonably has determined
to be prudent and consistent with industry practice. The Company
and the Company Subsidiaries are in material compliance with their
insurance policies and are not in default under any of the material
terms thereof, each such policy is outstanding and in full force
and effect, all premiums and other payments due under any material
policy have been paid, and all claims thereunder have been filed in
due and timely fashion, except, in each case, as would not,
individually or in the aggregate, reasonably be expected to have a
Company Material Adverse Effect.
(u) Intellectual Property . Except as would not,
individually or in the aggregate, reasonably be expected to have a
Company Material Adverse Effect, (i) the Company and each
Company Subsidiary owns or otherwise has the right to use, all
intellectual property rights, including all trademarks, trade
dress, trade names, service marks, domain names, patents,
inventions, trade secrets, know-how, works of authorship and
copyrights therein, that are used in the conduct of their existing
businesses and all rights relating to the plans, design and
specifications of any of its branch facilities (" Proprietary
Rights ") free and clear of all liens and any claims of
ownership by current or former employees, contractors, designers or
others and (ii) neither the Company nor any of the Company
-12-
Subsidiaries is materially infringing, diluting,
misappropriating or violating, nor has the Company or any or the
Company Subsidiaries received any written (or, to the knowledge of
the Company, oral) communications alleging that any of them has
materially infringed, diluted, misappropriated or violated, any of
the Proprietary Rights owned by any other person. Except as would
not, individually or in the aggregate, reasonably be expected to
have a Company Material Adverse Effect, to the Company’s
knowledge, no other person is infringing, diluting,
misappropriating or violating, nor has the Company or any or the
Company Subsidiaries sent any written communications since
January 1, 2006 alleging that any person has infringed,
diluted, misappropriated or violated, any of the Proprietary Rights
owned by the Company and the Company Subsidiaries.
(v) Brokers and Finders . No broker, finder or investment
banker is entitled to any financial advisory, brokerage,
finder’s or other fee or commission in connection with this
Agreement or the Warrant or the transactions contemplated hereby or
thereby based upon arrangements made by or on behalf of the Company
or any Company Subsidiary for which the Investor could have any
liability.
Article III
Covenants
3.1 Commercially Reasonable Efforts .
(a) Subject to the terms and conditions of this Agreement, each
of the parties will use its commercially reasonable efforts in good
faith to take, or cause to be taken, all actions, and to do, or
cause to be done, all things necessary, proper or desirable, or
advisable under applicable laws, so as to permit consummation of
the Purchase as promptly as practicable and otherwise to enable
consummation of the transactions contemplated hereby and shall use
commercially reasonable efforts to cooperate with the other party
to that end.
(b) If the Company is required to obtain any stockholder
approvals set forth on Schedule C , then the Company shall
comply with this Section 3.1(b) and Section 3.1(c). The
Company shall call a special meeting of its stockholders, as
promptly as practicable following the Closing, to vote on proposals
(collectively, the " Stockholder Proposals ") to
(i) approve th
|